Okyo Pharma: Funding, Investors & Team (Oct 2026)
Okyo Pharma specializes in developing innovative treatments for eye diseases with significant lack of effective options, and also in non-opioid analgesics for managing chronic pain.
Okyo Pharma has raised $4.0M across 1 funding round on record, the most recent an undisclosed round of $4.0M announced in Sep 2023.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Okyo Pharma Company Profile and Key Stats
Latest funding round on record: Sep 2023.
Okyo Pharma Funding Rounds
Okyo Pharma Founders and Leadership Team
Contact details for the Okyo Pharma team: 1 of 1 has an email address on file.
Start 14-day free trial →Okyo Pharma Funding Compared to Other Biotechnology Startups
Okyo Pharma's latest round of $4.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Okyo Pharma in Biotechnology and London
Companies Similar to Okyo Pharma
Microbiotica develops treatments involving live bacteria found in the human microbiome, aiming to identify…
OMass Technologies is a drug discovery company exploiting novel mass spectrometry platforms to develop…
HydRegen, based in Oxford, UK, is a biotech firm that offers eco-friendly alternatives for the production of…
R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…
The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…
Argonaute RNA company research projects build on existing intellectual property.
An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…
ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
Okyo Pharma Funding FAQs
What does Okyo Pharma do?
Okyo Pharma specializes in developing innovative treatments for eye diseases with significant lack of effective options, and also in non-opioid analgesics for managing chronic pain.
How much funding has Okyo Pharma raised?
Okyo Pharma has raised $4.0M across 1 round on record. The most recent is an undisclosed round of $4.0M announced in Sep 2023.
When did Okyo Pharma last raise funding?
Okyo Pharma's most recent funding round on record is an undisclosed round of $4.0M, announced in Sep 2023.
Who is the CEO of Okyo Pharma?
Gary Jacob is listed as CEO at Okyo Pharma.
Where is Okyo Pharma headquartered?
Okyo Pharma is based in London, England, United Kingdom.
How many employees does Okyo Pharma have?
Okyo Pharma is in the 1-10 employee band.
How does Okyo Pharma's funding compare to other Biotechnology startups?
Okyo Pharma's latest round of $4.0M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Okyo Pharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Okyo Pharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.